Imiglucerase
Mar 01, 2019
Cost ineffective Orphan Drugs limit the access
Rare diseases are mostly serious, chronic and life-threatening, associated with both psychological as well as financial burdens. In addition, only a few of them have effective drug treatment available. The European Union (EU) definition of a rare disease is one that affects fewer than 5 in 10,000 people. These affe...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
